Glaucoma News

Abia Community Receives Free Eye Care and Glasses for 216 Beneficiaries In a heartwarming display of community-focused healthcare, a recent medical outreach in Abia State has brought the gift of clear vision to hundreds of residents. The initiative, which provided comprehensive eye screenings and free prescription glasses, directly impacted 216 beneficiaries, offering them not just […]

California’s Child Vision Care Crisis Is Deepening For many of California’s children, the world is literally out of focus, and the problem is growing worse. A silent epidemic of untreated vision issues is sweeping through the state’s youngest generation, with profound consequences for their education, development, and future. Despite California’s reputation as a leader in

FDA Recalls Eye Drops Sold Nationwide, Including San Antonio In a significant move to protect public health, the U.S. Food and Drug Administration (FDA) has issued a nationwide recall for several brands of over-the-counter eye drops. The alert, issued in early April 2026, specifically names products that were distributed and sold in major retailers across

The Future of Cataract Surgery: 2026 Innovations and Breakthroughs The landscape of ophthalmology is undergoing a radical transformation. As we stand in 2026, cataract surgery is no longer just a procedure to restore vision; it has evolved into a pinnacle of precision medicine, artificial intelligence, and personalized patient care. Driven by relentless innovation, the operating

Major Eye Drop Recall: Over 3 Million Bottles Pulled Nationwide A significant and urgent recall has been issued for several brands of eye drops, with more than 3 million bottles being pulled from store shelves and online retailers across the United States. This sweeping action, impacting products sold at major national chains, underscores a critical

California’s Children Face a Growing Crisis in Vision Care Access For over 1.5 million low-income children in California, seeing the world clearly—and succeeding in it—is becoming an uphill battle. These children rely on Medi-Cal, the state’s Medicaid program, for essential health services, including vision care. However, a systemic and growing crisis in access to eye

Immunovant Stock Plummets After Thyroid Eye Disease Trial Setback The world of biotech investing is not for the faint of heart, a truth hammered home yet again as shares of Immunovant, Inc. (NASDAQ: IMVT) went into a tailspin. The catalyst? A significant and unexpected setback in a crucial late-stage clinical trial, sending shockwaves through the

Understanding Astigmatism: A Common Eye Condition Affecting Millions Have you ever experienced blurred or distorted vision at all distances, even with your glasses on? Do lights at night appear with annoying streaks or halos? If so, you might be one of the millions of people worldwide living with astigmatism. Far from being a disease or

Immunovant’s Batoclimab Fails Phase 3 Trial for Thyroid Eye Disease The landscape for treating Thyroid Eye Disease (TED), a painful and vision-threatening autoimmune condition, has seen significant innovation in recent years. However, the path forward is not without its setbacks. In a significant development, Immunovant Inc. has announced that its lead investigational drug, batoclimab, did